Sign Up to like & get
recommendations!
2
Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15020619
Abstract: Despite the rapid development in hidradenitis suppurativa (HS) research, the immediate introduction of potent therapeutic compounds in clinical trials and the lack of definitive outcome measures have led to the discontinuation of potential therapeutic compound…
read more here.
Keywords:
seboskin model;
enables preclinical;
therapeutic candidates;
model enables ... See more keywords